Tarsus Pharmaceuticals ($TARS) Insider Trading & Smart Money Activity
Tarsus Pharmaceuticals, Inc. ($TARS) has 14 insider trades on file. In the last 12 months on the open market, no insider bought and 3 insiders sold ($1.84M), net -$1.84M.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 3
- Net insider $ (12 mo)
- -$1.84M
- Congress trades (12 mo)
- 0
- 13F moves on file
- 0
- Analyst ratings on file
- 0
TARS insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 3 · $1.84M | 0 / 0 | 0 / 0 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All TARS insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | David Pyott | Buy (Grant or award) | 3.22K sh | +1.7% | -6.6% | — | |||||
| Insider | Scott Morrison | Buy (Grant or award) | 2.42K sh | +1.7% | -6.6% | — | |||||
| Insider | Link William Phd | Buy (Grant or award) | 3.84K sh | +1.7% | -6.6% | — | |||||
| Insider | Andrew Goldberg | Buy (Grant or award) | 2.42K sh | +1.7% | -6.6% | Read | |||||
| Insider | Jeffrey FarrowChief Financial Officer and Chief Strategy Officer | Sell (Open-market sale) | 14.40K sh | $877.44K | +8.8% | -5.1% | — | ||||
| Insider | Link William Phd | Sell (Open-market sale) 10b5-1 | 12.50K sh | $776.50K | +2.8% | -7.0% | — | ||||
| Insider | Katherine Goodrich | Sell (Open-market sale) 10b5-1 | 2.95K sh | $183.38K | +2.8% | -7.0% | Read | ||||
| Insider | Wendy Yarno | Sell (Option exercise) | 2.95K sh | +2.6% | -4.3% | Read | |||||
| Insider | Wendy Yarno | Buy (Option exercise) | 2.95K sh | +2.6% | -4.3% | Read | |||||
| Insider | Scott Morrison | Sell (Option exercise) | 2.95K sh | +2.6% | -4.3% | Read | |||||
| Insider | Link William Phd | Buy (Option exercise) | 2.95K sh | +2.6% | -4.3% | Read | |||||
| Insider | Andrew Goldberg | Sell (Option exercise) | 2.95K sh | +2.6% | -4.3% | Read | |||||
| Insider | Andrew Goldberg | Buy (Option exercise) | 2.95K sh | +2.6% | -4.3% | Read | |||||
| Insider | Bhaskar Chaudhuri | Sell (Option exercise) | 2.95K sh | +2.6% | -4.3% | Read |
1W / 1M / 6M = how TARS moved from the trade or filing date.
Insider trading in TARS: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Link William Phd | 3 | -$776.50K | Jun 25, 2026 | ||
| Andrew Goldberg | 3 | — | Jun 25, 2026 | ||
| Scott Morrison | 2 | — | Jun 25, 2026 | ||
| David Pyott | 1 | — | Jun 25, 2026 | ||
| Jeffrey Farrow | Chief Financial Officer and Chief Strategy Officer | 1 | -$877.44K | Jun 16, 2026 | |
| Katherine Goodrich | 1 | -$183.38K | Jun 15, 2026 | ||
| Wendy Yarno | 2 | — | Jun 12, 2026 | ||
| Bhaskar Chaudhuri | 1 | — | Jun 12, 2026 |
Frequently asked questions
Are TARS insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 3 insiders made 3 open-market sales worth $1.84M, a net -$1.84M.
What is the latest insider trade in TARS?
David Pyott filed a buy (grant or award) of 3.22K sh on Jun 25, 2026.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.